Humanigen (HGEN) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

External links

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Agriculture Air Environment Environmental Materials Nature Nuclear Offset Package Packaging Raw Materials Regenerative Waste Access Attrition Benefits Black California Consumer Privacy Act Collective Bargaining Community Customer Cybersecurity Data Privacy Data Security Death Employee General Data Protection Regulation Health and Safety Health Care Healthcare Hire Human Capital Human Resources Injury Philanthropic Privacy Product Safety Recall Recruitment Reimbursement Retention Safety Satisfaction Skills Society Stakeholder Supplier Supply Chain Training Union Volunteer Workers Action Plan Assessment Assurance Attorneys General Audit Bribery Chronic Class Action Lawsuit Commitment Corporate Governance Department of Ethics Executive Compensation Expert Fraud Goals Incentive Independence Independent Innovation Investigation Lawsuit Leadership Litigation Long-term Majority Oversight Plaintiff Purpose R&D Recoup Reputation Reputational Research and Development Responsibility Responsible Strategy Targets Tax

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

The 2022 Annual Meeting of Stockholders (the “Annual Meeting”) of Humanigen, Inc. (the “Company”) was held on June 9, 2022. Proxies for the Annual Meeting were solicited by the Board of Directors of the Company (the “Board”) pursuant to Section 14(a) of the Securities Exchange Act of 1934, as amended, and there was no solicitation in opposition. There were 70,378,977 shares of common stock entitled to vote at the Annual Meeting. A total of 46,073,128 shares were represented at the Annual Meeting in person or by proxy. The final votes on the proposals presented at the Annual Meeting were as follows:

Proposal No. 1

Cameron Durrant, M.D, MBA, Ronald Barliant, JD, Rainer Boehm, M.D., MBA, Cheryl Buxton, MSc.., Dale Chappell, M.D., MBA, John Hohneker, M.D. and Kevin Xie, Ph.D. were elected by a plurality of the votes entitled to vote on the election of directors, to hold office until the 2023 Annual Meeting of Stockholders by the following vote (in each case until their successors are elected and qualified, or until their earlier death, resignation or removal):

Nominee	For	Withheld	Broker Non-Votes
Cameron Durrant, M.D, MBA	30,395,933	506,316	15,170,879
Ronald Barliant, JD	29,934,474	967,775	15,170,879
Rainer Boehm, M.D., MBA	29,143,866	1,758,383	15,170,879
Cheryl Buxton, MSc.	27,748,372	3,153,877	15,170,879
Dale Chappell, M.D., MBA	30,521,271	380,978	15,170,879
John Hohneker, M.D.	29,513,077	1,389,172	15,170,879
Kevin Xie, Ph.D.	29,532,855	1,369,394	15,170,879

Proposal No. 2

The selection by the Audit Committee of the Board of HORNE LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022 was ratified by the following vote:


For	Against	Abstain
45,307,312	400,976	364,840

Proposal No. 3

The compensation paid to the Company’s named executive officers, as disclosed pursuant to